Online citations, reference lists, and bibliographies.
← Back to Search

Noninvasive Routes Of Proteins And Peptides Drug Delivery

Jitendra, P. Sharma, Sumedha Bansal, Arunabha Banik
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Recent advances in the field of pharmaceutical biotechnology have led to the formulation of many protein and peptide-based drugs for therapeutic and clinical application. The route of administration has a significant impact on the therapeutic outcome of a drug. The needle and syringe is a well established choice of protein and peptide delivery which has some drawback related to patient and to formulation such as pain, cost, sterility etc. Thus, the noninvasive routes which were of minor importance as parts of drug delivery in the past have assumed added importance in protein and peptide drug delivery and these include nasal, ophthalmic, buccal, vaginal, transdermal and pulmonary routes. The pharmaceutical scientists have some approaches to develop the formulations for protein and peptide delivery by noninvasive routes. But, due to the physiochemical instability and enzymatic barrier of proteins and peptides there are several hurdle to develop suitable formulation. So there is need of penetration enhancers, enzyme inhibitors and suitable vehicles for noninvasive delivery to increase the bioavailability. In this review, the aim is to focus on the approaches to formulation of protein and peptide based drug administration by noninvasive route.
This paper references
10.1007/BF02976326
Development of luteinizing hormone releasing hormone (LHRH) delivery systems for vaginal mucosal route
K. Han (1995)
10.1016/J.JCONREL.2006.04.012
Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Y. Sudhakar (2006)
10.2165/00003088-200342130-00003
Absorption Enhancers for Nasal Drug Delivery
S. Davis (2003)
10.3109/03602538308991382
A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.
M. Hichens (1983)
10.2174/1389557023406007
Biomembrane permeability of peptides: strategies to improve their mucosal uptake.
A. Bernkop-Schnürch (2002)
STRUCTURE AND FUNCTION OF THE ORAL MUCOSA AND IMPLICATIONS FOR DRUG DELIVERY
C. Squier (1996)
Nasal systemic drug delivery
Y. Chien (1989)
10.1001/JAMA.1963.73700210020020A
Treatment of diabetes insipidus with synthetic vasopressin.
A. Spiegelman (1963)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
10.3109/03639049309069342
Characterization of in Vitro Transdermal Iontophoretic Delivery of Insulin
A. Banga (1993)
10.1046/j.1365-3083.1996.d01-320.x
Local Intravaginal Vaccination of the Female Genital Tract
L. Wassén (1996)
10.1023/A:1015878222769
Enhanced Bioavailability of Subcutaneously Injected Insulin by Pretreatment with Ointment Containing Protease Inhibitors
M. Takeyama (2004)
BIOADHESIVE POLYMER SYSTEMS FOR PEPTIDE DELIVERY
H. Junginger (1990)
10.1016/S1461-5347(98)00099-6
Dry powder formulations for pulmonary delivery
R. Malcolmson (1998)
10.1016/S0010-7824(99)00102-X
Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
E. Amaral (1999)
10.1038/nrd1067
Challenges for the oral delivery of macromolecules
M. Goldberg (2003)
10.1002/CHIN.199503310
Formulation and Delivery of Proteins and Peptides. Design and Development Strategies.
J. Cleland (1995)
10.2174/1389200033489488
Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.
S. Koevary (2003)
Nasal absorption of nafarelin acetate, the decapeptide [E-Nal
ST Anik (1985)
10.1016/S0010-7824(01)00217-7
Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM).
S. Garg (2001)
10.2174/156720107780362339
Recent advances in protein and peptide drug delivery systems.
Dhirendra Kumar Malik (2007)
10.1016/S1461-5347(00)00295-9
Transdermal drug delivery: overcoming the skin's barrier function.
Naik (2000)
10.1038/NBT1207-1331
Pfizer dumps Exubera
G. Mack (2007)
10.1513/PATS.200403-023MS
Drug delivery devices: issues in drug development.
P. Byron (2004)
10.2337/diacare.11.9.750
Reduction of Blood Glucose Concentration With Insulin Eye Drops
G. Chiou (1988)
Thiomers: A New Generation of Mucoadhesive Polymers
M. Wagh (2009)
10.1203/00006450-198002000-00082
HYPOGLYCEMIA AFTER LIPOSOMIZED INSULIN IN THE RAT: 55
A. Moupti (1980)
10.1615/CRITREVTHERDRUGCARRIERSYST.V19.I2.20
Oral delivery of proteins: progress and prognostication.
R. Shah (2002)
10.1002/JPS.2600760709
Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity.
C. Mcmartin (1987)
10.1016/S0302-4598(99)00056-2
Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule.
T. Zewert (1999)
10.1016/S1773-2247(06)50003-6
Oral insulin delivery systems based on complexation polymer hydrogels
M. Morishita (2006)
10.1615/CRITREVTHERDRUGCARRIERSYST.V23.I4.20
Formulation and physiological factors influencing CNS delivery upon intranasal administration.
Tushar K Vyas (2006)
10.1016/S0169-409X(97)00076-8
Peptide drug delivery: Colonic and rectal absorption
M. Mackay (1997)
10.3109/9780849379529
Protein formulation and delivery
E. J. Mcnally (2008)
10.1016/0378-5173(89)90148-8
Influence of molecular weight and charge on nasal absorption of dextran and DEAE-dextran in rabbits
Maitani Yoshie (1989)
10.1186/rr58
The lung as a route for systemic delivery of therapeutic proteins and peptides
R. Uchenna Agu (2001)
10.1089/JOP.1988.4.165
Systemic delivery of polypeptides with molecular weights of between 300 and 3500 through the eyes.
G. Chiou (1988)
10.1023/A:1012161313701
Macromolecules as Novel Transdermal Transport Enhancers for Skin Electroporation
R. Vanbever (2004)
10.1023/A:1018915710318
Effect of Formulation Additives upon the Intranasal Bioavailability of a Peptide Drug: Tetracosactide (ACTH1−24)
P. Wüthrich (2004)
10.1023/A:1016418523014
Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles
A. Dyer (2004)
10.1016/0378-5173(82)90111-9
Effective vaginal absorption of insulin in diabetic rats and rabbits using polyacrylic acid aqueous gel bases
Morimoto Kazuhiro (1982)
Development and Evaluation of Controlled Release Nasal Drug Delivery Systems of Apomorphine
MI Ugwoke (1999)
10.3109/03602538308991387
Absorption from the vagina.
D. Benziger (1983)
Advantage of a new colloidal drug delivery system in insulin treatment of streptozotocininduced diabetic rats
Damage (1986)
Protein formulation and delivery. In: McNally EJ, editor
AR Clark (2000)
10.1016/J.IJPHARM.2005.01.022
Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium.
Nazila Salamat-Miller (2005)
10.1111/j.2042-7158.1985.tb05024.x
Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel
K. Morimoto (1985)
10.1615/CRITREVTHERDRUGCARRIERSYST.V14.I4.20
Pulmonary drug delivery: physiologic and mechanistic aspects.
J. Yu (1997)
10.1023/A:1012126301290
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
M. P. Desai (2004)
10.1023/A:1018955631835
Hydrogel-Based lontotherapeutic Delivery Devices for Transdermal Delivery of Peptide/Protein Drugs
A. Banga (2004)
10.1016/S0304-4165(00)00051-9
Intestinal transport and metabolism of glucose-conjugated kyotorphin and cyclic kyotorphin: metabolic degradation is crucial to intestinal absorption of peptide drugs.
T. Mizuma (2000)
10.1021/JS980076H
Novel approaches for oral delivery of macromolecules.
A. Fasano (1998)
[Drug delivery to target the posterior segment of the eye].
F. Béhar-Cohen (2004)
10.1023/A:1015921101465
Absorption of Polyethylene Glycols 600 Through 2000: The Molecular Weight Dependence of Gastrointestinal and Nasal Absorption
M. Donovan (2004)
10.1016/S0168-3659(97)00155-7
Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment.
L. Langkjaer (1998)
10.1517/17425247.2.3.533
Emerging strategies for the transdermal delivery of peptide and protein drugs
Yannic B. Schuetz (2005)
10.1016/J.EJPS.2004.03.015
Development and in vivo evaluation of an oral insulin-PEG delivery system.
P. Calceti (2004)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1016/0039-6257(85)90109-2
Ocular drug bioavailability from topically applied liposomes.
V. H. Lee (1985)
Permeation enhancers in the transmucosal delivery of macromolecules.
S. Sharma (2006)
10.1007/BF01062110
Effect of route of administration and distribution on drug action
L. Benet (2005)
10.1038/SJ.MT.6300324
Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea.
L. A. Johnson (2008)
Oral delivery of peptide drugs: barriers and developments.
J. Hamman (2005)
10.3109/00016349109007166
Vaginal bromocriptine in hyperprolactinemic patients and puerperal women
Valerio Maria Jasonni (1991)
Vaginal Bromocriptine: Pharmacology and Effect on Serum Prolactin in Normal Women
M. Vermesh (1988)
10.1097/00004397-199803820-00003
The epidemiology of diabetes mellitus and diabetic retinopathy.
J. C. Sánchez-Thorin (1998)
Indian Journal of Pharmaceutical Sciences 375 peptides and proteins
M Vermesh (2011)
10.1023/A:1007522114438
Synergistic Effect of Enhancers for Transdermal Drug Delivery
S. Mitragotri (2004)
10.1016/0168-3659(95)00055-D
Penetration enhancement effect of Pz-peptide, a paracellularly transported peptide, in rabbit intestinal segments and Caco-2 cell monolayers
W. Yen (1995)
10.1021/BC050322Y
Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
A. Basu (2006)
10.1002/JPS.2600730523
Nasal absorption of nafarelin acetate, the decapeptide [D-Nal(2)6)]LHRH, in rhesus monkeys. I.
S. T. Anik (1984)
10.1007/BF00257514
Dose-response curves after in vivo experimental chemotherapy: Influence of rouze of administration on biological outcomes
J. V. Moore (2004)
10.1185/030079906X132695
Pulmonary delivery of insulin
J. S. Patton (2006)
10.1016/S0168-3659(99)00256-4
Development of controlled drug release systems based on thiolated polymers.
A. Bernkop-Schnürch (2000)
10.1016/J.ADDR.2005.08.006
Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
M. E. Myles (2005)
10.1016/S1359-6446(97)01011-8
Prodrug strategies to enhance the intestinal absorption of peptides
S. Gangwar (1997)
10.1016/J.JCONREL.2004.01.027
Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats.
C. Bosquillon (2004)
10.2165/00063030-200519030-00003
Oral Delivery of Peptide Drugs
J. Hamman (2012)
10.1023/A:1015992828666
Synthesis of Palmitoyl Derivatives of Insulin and Their Biological Activities
M. Hashimoto (2004)
10.1016/j.ddtec.2005.05.018
Buccal drug delivery: A challenge already won?
S. Rossi (2005)
10.1016/J.JCONREL.2004.11.034
The vagina as a route for systemic drug delivery.
Alamdar Hussain (2005)
10.1016/S0378-5173(01)00708-6
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.
L. Illum (2001)
10.1254/JJP.35.203
Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
T. Aoyama (1984)
10.1517/17425247.2.2.201
Transporters and receptors in ocular drug delivery: opportunities and challenges
S. Dey (2005)
10.1201/b14099-22
VAGINAL DELIVERY OF CALCITONIN BY HYALURONIC ACID FORMULATIONS
J. Richardson (1999)
10.1016/S1461-5347(00)00302-3
Enhancing paracellular permeability by modulating epithelial tight junctions.
Ward (2000)
10.1023/A:1026118813943
Pulmonary Absorption of Insulin Mediated by Tetradecyl-β-Maltoside and Dimethyl-β-Cyclodextrin
Alamdar Hussain (2004)
The entrapment of biologically active substances in liposomes. I. Effect of oral administration of liposomally entrapped insulin in normal rats
V Dobre (1983)
10.1128/IAI.66.1.322-329.1998
Immunization of the Female Genital Tract with a DNA-Based Vaccine
J. Livingston (1998)
10.1016/J.ADDR.2006.01.003
Tight junction modulation and its relationship to drug delivery.
N. Salama (2006)
10.1016/J.ADDR.2005.07.009
Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.
M. I. Ugwoke (2005)
10.1007/s11095-005-6137-z
Region-Dependent Role of the Mucous/Glycocalyx Layers in Insulin Permeation Across Rat Small Intestinal Membrane
Y. Aoki (2005)
10.1067/MOB.2002.118309
Randomized trial of concurrent oxytocin with a sustained-release dinoprostone vaginal insert for labor induction at term.
F. C. Christensen (2002)
10.1007/978-1-4615-2898-2_9
Rectal and vaginal absorption of peptides and proteins
S. Muranishi (1993)
10.1016/S1567-5769(01)00143-6
Interleukin-2 liposomes for primary immune deficiency using the aerosol route.
R. Ten (2002)
10.1016/S0167-7799(98)01186-X
The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals.
D. Pettit (1998)
10.1016/0024-3205(88)90152-X
Systemic delivery of enkephalin peptide through eyes.
G. Chiou (1988)
10.1517/17425247.2.3.507
Buccal drug delivery
J. Smart (2005)
10.1080/026520499289059
Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres.
B. Bittner (1999)
10.1016/0378-5173(85)90230-3
Ocular delivery of progesterone using a bioadhesive polymer
Ho-Wah Hui (1985)
10.1023/A:1016070710397
Synergistic Effect of Electric Field and Ultrasound on Transdermal Transport
J. Kost (2004)
Lack of age-associated immune dysfunction in mucosal-associated lymph nodes.
M. Szewczuk (1981)
10.1046/j.1341-8076.2003.00091.x
Six hourly vaginal misoprostol versus intracervical dinoprostone for cervical ripening and labor induction
N. Agarwal (2003)
10.1016/J.JCONREL.2005.10.029
Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
M. Morishita (2006)
10.1016/S0378-5173(03)00034-6
Transdermal iontophoresis of insulin. II. Physicochemical considerations.
O. Pillai (2003)



This paper is referenced by
10.1016/J.PROGPOLYMSCI.2014.07.010
Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review
A. Sosnik (2014)
10.1016/j.jconrel.2014.10.003
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system.
L. Guilleminault (2014)
10.4155/tde-2015-0012
Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.
Vibhuti Agrahari (2016)
10.1016/j.matpr.2020.07.465
Vibrational spectroscopic, DFT studies and molecular docking on (2R)-2-acetamido-N-benzyl-3-methoxy propanamide as an antineuropathic pain drug
A. Anuradha (2020)
10.4995/thesis/10251/100854
Development of new artificial insemination extenders supplemented with GnRH analogues to induce ovulation and proteomic characterization of rabbit semen
Lucía Casares Crespo (2018)
Optimized preparation of lysozyme loaded dextran-chitosan nanoparticles using D-optimal design
Taraneh Hadi Esfahani (2019)
10.1080/08927022.2017.1367094
Molecular mechanism of transdermal co-delivery of interferon-alpha protein with gold nanoparticle – a molecular dynamics study
R. Gupta (2018)
Pharmaceutics, Drug Delivery and Pharmaceutical Technology Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1(R14A) for the Treatment of Autoimmune Diseases
Liang Ying Jin (2016)
Using ion-pairs to modify salbutamol delivery to the lungs
Bridie Leigh Dutton (2018)
10.3109/03639045.2012.737332
A design of experiments to optimize a new manufacturing process for high activity protein-containing submicron particles
Javier O Morales (2013)
10.5772/58538
Nanoparticle Insulin Drug Delivery — Applications and New Aspects
H. Elçioğlu (2014)
10.1016/j.theriogenology.2018.05.008
Protection of GnRH analogue by chitosan-dextran sulfate nanoparticles for intravaginal application in rabbit artificial insemination.
L. Casares-Crespo (2018)
10.22159/ajpcr.2017.v10i8.18274
NON INVASIVE DELIVERY OF PROTEIN AND PEPTIDE DRUGS: A REVIEW
P. Kotra Lakshmi (2017)
10.1016/j.neuint.2019.02.021
Oral administration of carvacrol/β-cyclodextrin complex protects against 6-hydroxydopamine-induced dopaminergic denervation
C. Ribeiro (2019)
10.1016/j.ejpb.2014.03.004
Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Ana Fortuna (2014)
10.1007/s12325-019-01075-5
Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally
Pablo Zubiaur (2019)
10.1007/978-3-319-95807-1_24
Ocular Delivery of Peptides and Proteins
R. Dahiya (2018)
10.1016/j.xphs.2016.04.005
Design of an In Situ Cross-Linked Eutectic Tablet for Enhanced Delivery of Gastro-Sensitive Proteins and Peptides.
Bibi F Choonara (2016)
10.5772/INTECHOPEN.86830
A Noninvasive, Orally Stable, Mucosa-Penetrating Polyvalent Vaccine Platform Based on Hepatitis E Virus Nanoparticle
Shizuo George Kamita (2019)
10.1016/bs.apcsb.2018.01.006
In Silico Tools and Databases for Designing Peptide-Based Vaccine and Drugs.
S. Usmani (2018)
10.1088/2399-1984/AADD34
Quantitative analysis of recombinant glucocerebrosidase brain delivery via lipid nanoparticles
Meir Goldsmith (2018)
Microemulsion as drug delivery system for Peptides and Proteins
Landge Anil (2018)
10.3390/molecules25153468
Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
Zachary Barry (2020)
10.1016/j.colsurfb.2014.05.025
Films loaded with insulin-coated nanoparticles (ICNP) as potential platforms for peptide buccal delivery.
Javier O Morales (2014)
10.1039/c6cp08775b
Transdermal cellular membrane penetration of proteins with gold nanoparticles: a molecular dynamics study.
R. Gupta (2017)
10.1016/j.ijpharm.2017.06.079
Chitosan centered bionanocomposites for medical specialty and curative applications: A review.
M. Ahmad (2017)
10.1007/s40199-019-00316-w
Review of recently used techniques and materials to improve the efficiency of orally administered proteins/peptides
Y. H. Y. Ibrahim (2019)
10.1016/J.AJPS.2013.09.003
The development of polycarbophil as a bioadhesive material in pharmacy
Zhaolu Zhu (2013)
10.1177/8755122518793256
Vulvodynia: A Review of the Literature
Bobbi Jo Loflin (2019)
10.1016/J.JDDST.2020.102104
Transdermal delivery of second-generation antipsychotics for management of schizophrenia; disease overview, conventional and nanobased drug delivery systems
Fatma S. El-Tokhy (2020)
10.1016/j.xphs.2015.10.025
Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases.
Liang Jin (2016)
10.1016/j.csbj.2019.09.004
Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery
Rajiv Bajracharya (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar